Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Gastrointestinal 9Gynecologic 5Thoracic 3Genitourinary 2Dermatologic 2Other 1

Conditions

Smoking Cessation 1Skin Cancer Prevention 1Melanoma 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Motivational Interviewing × Dermatologic × Clear all
NCT04899492 2024-11-07

RESPIRE

Institut Cancerologie de l'Ouest

Phase NA Terminated
22 enrolled
BreastDermatologicGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Melanoma, Smoking Cessation

NCT00709306 2018-08-31

The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention

Fox Chase Cancer Center

Phase NA Completed
197 enrolled 11 charts
Dermatologic

Skin Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡